Tocilizumab treatments in patients with noninfectious uveitis demonstrated high rates of success at 1 year follow ups.

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...

The global peripheral intravenous catheter market is projected to experience robust growth over the next decade, with market size expected to exceed USD 13,006.1 million by 2034, up from USD 6,489.3 ...

AngioDynamics, a medical device company - manufactures port catheters widely used for patients needing regular IV treatments or medications.However, recent reports have raised concerns regarding certa ...